Anthemis Exponential Ventures
VC Fund
London, United Kingdom
Anthemis Exponential Ventures is a VC fund in London focused on FinTech and Medical Device. Anthemis Exponential Ventures invests in and supports startups that are driving innovation in technology and digital transformation. The firm provides capital, strategic guidance, and resources to help emerging companies scale and succeed. By focusing on cutting-edge developments and transformative ideas, Anthemis Exponential Ventures aims tofoster growth and advancement in the tech sector.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Anthemis Exponential Ventures invests in
Stages Anthemis Exponential Ventures invests in
Countries Anthemis Exponential Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- FinTech 6 (22%)
- Medical Device 6 (22%)
- Financial Services 6 (22%)
- Health Care 5 (19%)
- Information Technology 4 (15%)
Stage
- Seed 9 (33%)
- Series A 5 (19%)
- Series B 3 (11%)
- Series C 2 (7%)
- Venture - Series Unknown 2 (7%)
Country
- United Kingdom 7 (26%)
- United States 6 (22%)
- Kenya 1 (4%)
- Belgium 1 (4%)
- United Arab Emirates 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Erica Young
Head of Operational Team
|
Head of Operational Team | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Feel Therapeutics
|
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | $830K / Convertible Note / Apr 10, 2024 | |
|
Feel Therapeutics
|
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | Jan 09, 2024 | |
Qover
|
Qover is an insurtech that enables companies and insurance providers to offer seamless, tech-driven insurance experiences.Qover’s modular embedded insurance orchestration platform provides meaningful insurance experiences to millions of users across 32 European countries, and works with longstanding partners like Revolut, Mastercard, NIO, Canyonand many others. | $30M / Series C / Jul 06, 2023 | |
|
Feel Therapeutics
|
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | $4.2M / Venture - Series Unknown / Aug 06, 2022 | |
YuLife
|
YuLife is a tech-driven insurance company on a mission to inspire life and turn financial products into a force for good. By harnessing the power of gamification and the latest behavioral science, YuLife insurance rewards healthy living and puts everyday wellness within reach of everyone. Founded in 2016, YuLife is headquartered in London andbacked by serial investors and VCs including Creandum, MMC Ventures, Notion Capital, LocalGlobe, and Anthemis Exponential Ventures. | $120M / Series C / Jul 07, 2022 | |
Apollo Agriculture
|
Apollo Agriculture is an agtech company that offers farmers access to agricultural inputs, financing, and advice. Apollo helps farmers in emerging markets maximize their profits. The company uses agronomic machine learning, remote sensing, and mobile phones to deliver a customized package of credit, high-quality farm inputs, and advice that candouble farm yields, starting in Kenya. Apollo assesses farmer credit risk and customizes each package to a farmer's specific location using satellite data, soil data, farmer behavior data, and crop yield models. | $40M / Series B / Mar 21, 2022 | |
|
Feel Therapeutics
|
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | $4M / Convertible Note / Feb 07, 2022 | |
|
Feel Therapeutics
|
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | $4M / Seed / Feb 07, 2022 | |
Numan
|
Numan is a startup which aims to tackle your tackle problem erectile dysfunction. | $41.5M / Series B / Sep 13, 2021 | |
|
YuLife
|
YuLife is a tech-driven insurance company on a mission to inspire life and turn financial products into a force for good. By harnessing the power of gamification and the latest behavioral science, YuLife insurance rewards healthy living and puts everyday wellness within reach of everyone. Founded in 2016, YuLife is headquartered in London andbacked by serial investors and VCs including Creandum, MMC Ventures, Notion Capital, LocalGlobe, and Anthemis Exponential Ventures. | $70M / Series B / Jul 14, 2021 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Anthemis Exponential Ventures invest in?
Anthemis Exponential Ventures invests primarily in FinTech, Medical Device and Financial Services startups, most often at Seed and Series A stage. Most of the 27 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anthemis Exponential Ventures?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Anthemis Exponential Ventures?
The team at Anthemis Exponential Ventures includes Erica Young (Head of Operational Team). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
